|
KLF12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.460430E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.058810E-01 |
| Normal-vs-Stage2 |
7.042600E-01 |
| Normal-vs-Stage3 |
2.470400E-01 |
| Normal-vs-Stage4 |
9.226200E-02 |
| Stage1-vs-Stage2 |
4.424000E-02 |
| Stage1-vs-Stage3 |
6.272200E-01 |
| Stage1-vs-Stage4 |
6.381400E-01 |
| Stage2-vs-Stage3 |
1.220400E-01 |
| Stage2-vs-Stage4 |
4.645900E-02 |
| Stage3-vs-Stage4 |
4.272200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.160810E-01 |
| Normal-vs-AfricanAmerican |
1.465580E-01 |
| Normal-vs-Asian |
8.318400E-02 |
| Caucasian-vs-AfricanAmerican |
5.692000E-01 |
| Caucasian-vs-Asian |
4.616800E-01 |
| AfricanAmerican-vs-Asian |
9.896600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.894040E-01 |
| Normal-vs-Female |
1.589400E-01 |
| Male-vs-Female |
9.322600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.583700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.454800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.775800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.534600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.208800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.445400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.214200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.155600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.342600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.280600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.759800E-01 |
| Classical-VS-Follicular |
8.46570002988045E-09 |
| Classical-VS-Other |
3.464800E-01 |
| Classical-VS-Normal |
1.060060E-02 |
| Tall-VS-Follicular |
7.801800E-04 |
| Tall-VS-Other |
3.979200E-01 |
| Tall-VS-Normal |
9.254000E-02 |
| Follicular-VS-Other |
3.474400E-01 |
| Follicular-VS-Normal |
8.645800E-02 |
| Other-VS-Normal |
9.098000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.904400E-01 |
| Normal-vs-N1 |
2.137400E-01 |
| N0-vs-N1 |
1.819840E-01 |
|
|
